IQ PharmaTek Limited, the investment company, is thrilled to announce the birth of AlbyPharma at Clonmel, which was formerly known as Suir Pharma Ireland. The manufacturing site was taken over this month (January-2017) with new ownership and management.
IQ PharmaTek group will operate the manufacturing site under the new name AlbyPharma which represents the heritage of County Tipperary in general and Clonmel Town. In addition, the new name will be in-line with IQ PharmaTek Group future vision.
The name AlbyPharma “All-bay Pharma” reflects the warmth received from the community of Clonmel. And the symbol in the logo is inspired by the ancient Triskele (Triple Spiral) as an everyday reminder to the roots and to push us to stay in constant forward motion and progress.
The manufacturing site is well-established according to the highest quality standards for producing generic medicines for more than 40 years and supplying various markets in Europe and for USA market since 1988.
AlbyPharma will remain committed to provide competitive CMO services to existing and new customers as well as offering innovative medications to address the evolving needs of patients worldwide.
We would like to take this opportunity to thank everyone involved with special thanks for the local community and its leadership for making the transition process smooth. We are fortunate and delighted to be part of a caring and compassionate community.
You can check our website at “www.albypharma.com” for future updates. In addition, you can subscribe to our social media platforms to stay tuned.
For any inquiries please contact us at: [email protected]
Dr. Azzam Hussein
MD-CEO, IQ PharmaTek LTD
Past. Present. Future…
The manufacturing site is well-established according to the highest quality standards for producing generic medicines for more than 40 years and supplying various markets in Europe and have been supplying the United States since 1988.
The site consists of two business units; the Antibiotic plant which is a dedicated FDA approved beta-lactam facility. It is self contained with facilities to support the entire production process and produce antibiotics in the following forms:
- Film coated tablets.
- Hard gelatine capsules.
- Powders for reconstitution.
The second business unit is the larger facility on site and produces solid dosage form tablets. Similar to the Antibiotic plant, it is self contained incorporating the entire production process. In addition, the main plant is equipped to produce and store controlled drugs with high security vaults and security systems throughout the plant to enhance security.